JPRN-jRCT2080222106未知1 期
A Phase I Clinical Study of BBI608 in Adult Patients with Advanced Solid Tumors
适应症
试验速览
- 阶段
- 1 期
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •- Signed, written informed consent
- •- Patients with histologically or cytologically confirmed solid tumor
- •- Patients of ECOG performance status of 0 or 1
排除标准
- •- Patients with any known untreated brain metastases
研究者
相似试验
未知
1 期
A Phase I Clinical Study of BBI608 Administered with Paclitaxel in Patients with Previously treated Unresectable/Recurrent Gastric CancerJPRN-jRCT2080222370Sumitomo Dainippon Pharma Co., Ltd.6
已完成
1 期
Clinical pharmacology study of BBI608JPRN-jRCT2080225351Sumitomo Dainippon Pharma. Co,.Ltd.70
已完成
1 期
A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic MalignanciesHematologic MalignancyNCT02352558Sumitomo Pharma America, Inc.15
已完成
1 期
A Phase Ib/II Study of BBI608 in Combination with Pembrolizumab in Patients with Metastatic Colorectal Cancermetastatic colorectal cancerJPRN-UMIN000023149ational Cancer Center Hospital East95
已完成
1 期
A Study of BBI608 in Adult Patients With Advanced MalignanciesCancer, Advanced MalignanciesNCT01775423Sumitomo Pharma America, Inc.87